SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-115292
Filing Date
2020-10-15
Accepted
2020-10-15 16:15:34
Documents
19
Period of Report
2020-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032919-1_8k.htm   iXBRL 8-K 28768
2 EXHIBIT 99.1 tm2032919d1_ex99-1.htm EX-99.1 19148
3 EXHIBIT 99.2 tm2032919d1_ex99-2.htm EX-99.2 22051
7 GRAPHIC tm20329191_ex99-1img001.jpg GRAPHIC 15633
8 GRAPHIC tm20329191_ex99-1img002.jpg GRAPHIC 27661
9 GRAPHIC tm20329191_ex99-2img001.jpg GRAPHIC 69191
10 GRAPHIC tm20329191_ex99-2img002.jpg GRAPHIC 84096
11 GRAPHIC tm20329191_ex99-2img003.jpg GRAPHIC 113279
  Complete submission text file 0001104659-20-115292.txt   687495

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyne-20201015.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20201015_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20201015_pre.xml EX-101.PRE 22708
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2032919-1_8k_htm.xml XML 3730
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 201241641
SIC: 2834 Pharmaceutical Preparations